Photocure ASA: Results for the third quarter of 2023 -Novemb

Oslo, Norway, 8 November 2023 - Photocure ASA today reported Hexvix®/Cysview® revenues of NOK 107.3 million in the third quarter of 2023 , and an EBITDA of NOK 3.3 million for the company....

Related Keywords

Oslo , Norway , China , Norwegian , Dan Schneider , Hexvix Cysview , Tolv Hillestad , Karl Storz , David Moskowitz , Erik Dahl , Stryker Corporation , Bladder Cancer Company , Corporate Communications , Oslo Stock Exchange , Chief Executive Officer , Blue Light Cystoscopy , Stock Exchange , Abuse Regulation , Norwegian Securities Trading , Group Controller , Markets ,